Oral fluid inflammatory biomarker profile in long COVID: evaluation of oral active and total MMP-8, MMP-9, and TIMP-1 in relation to BMI and disease status
6 affiliations
- 1Department of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Periodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
- 2Department of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- 3Outpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, Finland
- 4Outpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, Finland; Department of Hospital Hygiene and Infection Control, TYKS Turku University Hospital, Turku, Finland
- 5Department of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Division of Oral Diseases, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden
- 6Department of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Virology, University of Helsinki, Helsinki, Finland; Department of Infectious Diseases, Meilahti Vaccine Research Center MeVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Abstract
Background: Long COVID (LC) is characterized by persistent systemic symptoms, but its oral inflammatory profile remains unclear. This study evaluated oral inflammatory biomarkers, particularly matrix metalloproteinase (MMP) -8, -9 and their regulators in oral rinse samples from LC patients. Methods: This cross-sectional study analyzed oral rinse samples from 115 LC patients and 103 comparable controls. Periodontal inflammation was screened using a chair-side active MMP-8 (aMMP-8) point-of-care test (POCT). Biomarkers (aMMP-8, total MMP-8, MMP-9, TIMP-1, and MPO) were quantified and validated by Western blotting and gelatin zymography. Associations with LC and clinical variables were assessed using bivariate analysis and multivariable regression. Results: LC patients had significantly higher total MMP-8, MMP-9, TIMP-1, and MMP-9/TIMP-1 ratio (all P < 0.05 in both analyses). IFMA-measured active MMP-8 became independently associated with LC after multivariable adjustment. Chair-side aMMP-8 POCT showed a nonsignificant trend toward higher positivity in LC (16.5% vs 8.7%). BMI was positively associated with aMMP-8, tMMP-8 and tMMP-8/TIMP-1 molar ratio. Antidepressant use was associated with tMMP-8/TIMP-1 molar ratio. Western blotting confirmed active MMP-8 species and gingipain. Conclusion: These findings suggest an altered oral inflammatory biomarker profile in LC. The potential role of chair-side aMMP-8 POCT for screening oral inflammation in this population merits further investigation.
Related
- Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden
- FABP3, a Candidate Biomarker of Muscle Strength and Myositis Disease Activity in Patients with Idiopathic Inflammatory Myopathies
- Neutrophil-to-lymphocyte ratio (NLR) in relation to metabolic profile and dietary antioxidant quality in adults with non-alcoholic fatty liver disease
- Latent profile analysis of fertility motivation in women with inflammatory bowel disease: a cross-sectional study
- Gut Dysbiosis, Uremic Toxins, and NLRP3 Signaling in Chronic Kidney Disease: From Mechanistic Evidence to Clinical Biomarker Evaluation.
BibTeX
@article{aji2026oral,
title = {{Oral fluid inflammatory biomarker profile in long COVID: evaluation of oral active and total MMP-8, MMP-9, and TIMP-1 in relation to BMI and disease status}},
author = {Nur Rahman Ahmad Seno Aji and Julie Toby Thomas and Taina Tervahartiala and Ismo T. Räisänen and Mikko Varonen and Helena Liira and Mari Kanerva and Velina Vangelova-Korpinen and Timo Sorsa and Hanna Välimaa},
journal = {International Journal of Infectious Diseases},
year = {2026},
month = nov,
doi = {10.1016/j.ijid.2026.109183},
url = {https://doi.org/10.1016/j.ijid.2026.109183},
note = {CC BY},
}
RIS
TY - JOUR
TI - Oral fluid inflammatory biomarker profile in long COVID: evaluation of oral active and total MMP-8, MMP-9, and TIMP-1 in relation to BMI and disease status
AU - Nur Rahman Ahmad Seno Aji
AU - Julie Toby Thomas
AU - Taina Tervahartiala
AU - Ismo T. Räisänen
AU - Mikko Varonen
AU - Helena Liira
AU - Mari Kanerva
AU - Velina Vangelova-Korpinen
AU - Timo Sorsa
AU - Hanna Välimaa
PY - 2026
DA - 2026/11/04
JO - International Journal of Infectious Diseases
DO - 10.1016/j.ijid.2026.109183
UR - https://doi.org/10.1016/j.ijid.2026.109183
AB - Background: Long COVID (LC) is characterized by persistent systemic symptoms, but its oral inflammatory profile remains unclear. This study evaluated oral inflammatory biomarkers, particularly matrix metalloproteinase (MMP) -8, -9 and their regulators in oral rinse samples from LC patients. Methods: This cross-sectional study analyzed oral rinse samples from 115 LC patients and 103 comparable controls. Periodontal inflammation was screened using a chair-side active MMP-8 (aMMP-8) point-of-care test (POCT). Biomarkers (aMMP-8, total MMP-8, MMP-9, TIMP-1, and MPO) were quantified and validated by Western blotting and gelatin zymography. Associations with LC and clinical variables were assessed using bivariate analysis and multivariable regression. Results: LC patients had significantly higher total MMP-8, MMP-9, TIMP-1, and MMP-9/TIMP-1 ratio (all P < 0.05 in both analyses). IFMA-measured active MMP-8 became independently associated with LC after multivariable adjustment. Chair-side aMMP-8 POCT showed a nonsignificant trend toward higher positivity in LC (16.5% vs 8.7%). BMI was positively associated with aMMP-8, tMMP-8 and tMMP-8/TIMP-1 molar ratio. Antidepressant use was associated with tMMP-8/TIMP-1 molar ratio. Western blotting confirmed active MMP-8 species and gingipain. Conclusion: These findings suggest an altered oral inflammatory biomarker profile in LC. The potential role of chair-side aMMP-8 POCT for screening oral inflammation in this population merits further investigation.
SN - 1201-9712
SN - 1878-3511
ER -